Logo
Pharmidex are delighted to be one of sixteen partners in an EU Horizon 2020 grant - HeatNMof
April 12, 2022

HeatNMof is a heating-triggered drug release from nanometric metal-organic framework composites

The Initial Training Network HeatNMof aims to develop high quality training opportunities for 12 early-stage-researchers (ESRs) in the area of materials science, advanced characterization and biomedicine.


HeatNMof is training the next generation of materials scientists in nanomedicine to exploit heat-triggered release for delivery of anti-tumour drugs. The network is focusing on one of the most promising classes of nanocomposite carriers, inorganic nanoparticles (iNPs) associated to nanoscaled metal organic frameworks (nanoMOFs).


The successful development of this project, involving seven academic, three industrial partners, six partner organisations (5 universities and 1 company), will contribute to the improvement of the highly societal relevant cancer therapy..


Partners: Fundación IMDEA Energía (Coordinator), Universidad de Santiago de Compostela; Centre National de la Recherche Scientifique; Universiteit Antwerpen; Immaterial Labs Ltd; Institut National des Sciences Appliquees de Toulouse; Universitaet Hamburg; Fondazione Istituto Italiano di Tecnologia.; Nanoscale Biomagnetics SL; Isern Patentes Y Marcas M SL.


- Partner Organisations: Universidad Rey Juan Carlos; Universidad de Zaragoza, University of Cambridge; Universite de Nantes; Universita Degli Studi di Genova; Pharmidex.


Funding Institution/Program: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement Nº 860942.


Call: H2020-MSCA-ITN-2019 (ETN)


https://www.energy.imdea.org/research/projects/heatnmof

March 21, 2025
We’re pleased to announce that Janette Dalay Robertson , our Business Development Manager, and Ian Knowles , our Head of Respiratory, will be attending the 2nd SMR Molecular Glues Meeting on Friday, 21st March 2025 at GSK, Stevenage. This event is a fantastic opportunity to engage with fellow scientists, innovators, and industry leaders in the field of molecular glues. Janette and Ian are eager to connect, share insights, and explore new collaborations to advance drug discovery and development. If you’re attending, don’t hesitate to reach out – they would love to meet and discuss how Pharmidex can support your research and development goals! 🔗 More about the event: https://lnkd.in/d6yiTkUi
March 12, 2025
We’re excited to announce that Martin Barrett , our Head of Business Development, will be attending Medical Technology UK 2025 on 12-13 March at Coventry Building Society Arena! 🏥💡 Martin is looking forward to connecting with fellow industry leaders, researchers, and innovators to explore new collaborations and opportunities in advancing drug discovery and development. If you're attending, don’t miss the chance to meet him and discuss how Pharmidex can support your projects! 📅 Event: Medical Technology UK 2025 📍 Location: Coventry Building Society Arena 👥 Meet Martin: 12-13 March Let’s shape the future of medical technology and drug development together! 🔬💊
March 10, 2025
We’re excited to announce that Janette Dalay Robertson , our Business Development Manager, will be attending ELRIG Research & Innovation 2025 – Big Molecules & Big Data. 📍 Where: London, UK 🗓️ Event information ( https://lnkd.in/eRUnCsie ) Janette will be happy to connect with attendees to discuss how Pharmidex can support your drug discovery and development projects. Whether you're looking to explore partnerships or learn about our innovative solutions, Janette is eager to chat! 💬 Don’t miss this opportunity to explore exciting new business possibilities with Pharmidex . 🔎 Interested in scheduling a meeting in advance? Reach out today!
More Posts
Share by: